From: The impact of use of an intraoperative margin assessment device on re-excision rates
Tumor composition | ||
āIDC | 37 | 22.4% |
āDCIS | 32 | 19.4% |
āIDCā+āDCIS | 75 | 45.5% |
āILC | 11 | 6.7% |
āILCā+āDCIS | 1 | 0.6% |
āIPC | 2 | 1.2% |
āITC | 4 | 2.4% |
āITCā+āDCIS | 1 | 0.6% |
āPCIS | 1 | 0.6% |
āMetastatic sarcoma | 1 | 0.6% |
Tumor grade: | Ā | Ā |
āInvasive grade | ||
āā1 | 41 | 35% |
āā2 | 56 | 47% |
āā3 | 21 | 18% |
āIn-Situ grade | ||
āā1 | 20 | 20% |
āā2 | 52 | 51% |
āā3 | 29 | 29% |
Tumor/lesion size (cm) | ||
āMean (STD) | 1.5 (1.1) | Ā |
ā<1 | 51 | 35% |
ā1 to 2 | 58 | 40% |
ā>2 | 35 | 24% |